London, April 30, 2026, 20:04 (BST)
Aviva plc’s UK life arm is drawing more regulatory heat after the Bank of England unveiled plans to tighten capital requirements around funded reinsurance—a structure that lets life insurers offload long-term risks, typically to offshore reinsurers. The Prudential Regulation Authority is pushing for British life firms to set aside about 10% capital on average funded reinsurance deals, a notable jump from the current 2% to 4% range.
The timing is crucial here—funded reinsurance operates deep in the machinery of the bulk annuity market. In these deals, insurers assume responsibility for paying out company pensions, shifting risk away from employers. Aviva is a player in this space, alongside rivals such as Legal & General and Phoenix.
The PRA flagged that existing regulations downplay risk and tend to tilt the playing field toward funded reinsurance, compared with equivalent direct assets. Sam Woods, who serves as the Bank of England’s deputy governor for prudential regulation, warned that funded reinsurance “has the potential to undermine the resilience of insurers” if not handled properly. Right now, the regulator puts UK firms’ exposure in this area at around £40 billion. Bank of England
One catch: this is just a consultation for now, with feedback open until July 31, 2026. The PRA wants the new measures to kick in from July 1, 2027. Notably, any funded reinsurance deals fully transferring risk by Sept. 30, 2026 would be exempt from the updated rules.
Aviva and its rivals are left with breathing room to move on their deal pipelines—though they shouldn’t expect an easy ride. Skadden attorneys Robert A. Chaplin, Feargal Ryan, Caroline C. Jaffer and colleagues said Thursday that the new plans might “double or even triple” the capital needed for typical funded reinsurance transactions, while also putting extra hurdles in place for reinsurers with shakier footing. Skadden
Aviva’s solid shareholder returns face a new regulatory backdrop. Back in March, Group CEO Amanda Blanc told investors the company would “resume the share buyback” after 2025 results, this time at £350 million—a bump higher. The final dividend’s up 10%, and general insurance premiums climbed 18%. Aviva
Aviva disclosed in a Thursday filing that it snapped up 1,301,008 ordinary shares for cancellation on April 29, paying a volume-weighted average price of 622.44 pence per share. Following the move, Aviva will have 3,021,722,648 ordinary shares outstanding, with zero ordinary shares left in treasury.
The capital situation just got more complicated. Buybacks suggest there’s surplus capital on hand. But if the PRA’s proposal sticks as written, Aviva could end up committing extra capital to upcoming life-insurance deals involving funded reinsurance—much will hinge on which deals, which counterparties, and what collateral is in play.
Aside from annuities, Aviva is doubling down on health and protection—reporting Thursday that its DigiCare+ apps now serve over 673,500 protection customers. Digital GP bookings jumped 36% in 2025, reaching 61,300 appointments. “A more proactive and preventative approach” is what customers are after, said Fran Bruce, Aviva’s managing director for protection. Aviva
Aviva highlighted steady strength in commercial insurance distribution. According to its latest Broker Barometer, 95% of brokers surveyed anticipate business growth in the next year. “Optimism and ambition across broking” is how Michelle Taylor, Aviva’s broker distribution director, summed it up. Aviva
Tighter regulation could squeeze returns in what’s been one of the fastest-growing corners of the UK life sector, even as competition for pension-risk transfer deals stays fierce. Aviva, for now, isn’t grappling with balance sheet strain. The question is whether future annuity growth can still meet return targets once the PRA hands down its capital requirements.
